WO2012149180A3 - Colorant de suivi fluorescent - Google Patents

Colorant de suivi fluorescent Download PDF

Info

Publication number
WO2012149180A3
WO2012149180A3 PCT/US2012/035242 US2012035242W WO2012149180A3 WO 2012149180 A3 WO2012149180 A3 WO 2012149180A3 US 2012035242 W US2012035242 W US 2012035242W WO 2012149180 A3 WO2012149180 A3 WO 2012149180A3
Authority
WO
WIPO (PCT)
Prior art keywords
dual labeled
fluorescent tracking
directed
protein
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/035242
Other languages
English (en)
Other versions
WO2012149180A2 (fr
Inventor
Thomas Diller
Timothy Updyke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Publication of WO2012149180A2 publication Critical patent/WO2012149180A2/fr
Publication of WO2012149180A3 publication Critical patent/WO2012149180A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00Reference solutions for assays of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

La présente invention concerne des étalons protéiques doublement marqués, utiles pour la détermination simultanée de la masse moléculaire d'une protéine sujet ainsi que la masse relative (à savoir, la quantité) de la protéine sujet présente dans une piste d'électrophorèse. L'invention concerne également des procédés appropriés pour la préparation de tels étalons protéiques doublement marqués et des procédés d'utilisation de telles protéines doublement marquées pour déterminer simultanément la masse moléculaire et la quantité relative d'une protéine sujet. Des modes de réalisation supplémentaires permettent d'assurer un suivi fluorescent qui peut être utilisé pour surveiller la progression du front ionique à travers un gel d'électrophorèse. Des modes de réalisation supplémentaires concernent des procédés de fabrication d'un colorant de suivi fluorescent. Cependant, des modes de réalisation supplémentaires concernent des coffrets contenant un colorant de suivi fluorescent et un étalon protéique doublement marqué.
PCT/US2012/035242 2011-04-26 2012-04-26 Colorant de suivi fluorescent Ceased WO2012149180A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161479296P 2011-04-26 2011-04-26
US61/479,296 2011-04-26

Publications (2)

Publication Number Publication Date
WO2012149180A2 WO2012149180A2 (fr) 2012-11-01
WO2012149180A3 true WO2012149180A3 (fr) 2013-08-08

Family

ID=46201787

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/035242 Ceased WO2012149180A2 (fr) 2011-04-26 2012-04-26 Colorant de suivi fluorescent

Country Status (1)

Country Link
WO (1) WO2012149180A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778685B2 (en) * 2009-08-25 2014-07-15 Life Technologies Corporation Quantitative fluorescent protein standards
JP6629830B2 (ja) 2014-07-15 2020-01-15 バリタセル リミテッド 試料中の抗体濃度を測定する方法
US12259356B2 (en) 2020-12-07 2025-03-25 Bio-Rad Laboratories, Inc. Method and composition for quantifying protein using tagged standards

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090178926A1 (en) * 2006-07-21 2009-07-16 Invitrogen Corporation Sharply Resolving Labeled Protein Molecular Weight Standards
WO2011025781A1 (fr) * 2009-08-24 2011-03-03 Life Technologies Corporation Electrophorèse sur gel, imagerie et procédés, dispositifs, systèmes et matériaux d'analyse
WO2011031497A2 (fr) * 2009-08-25 2011-03-17 Life Technologies Corporation Standards de protéine fluorescente quantitative

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459272A (en) 1990-10-16 1995-10-17 Research Corporation Technologies Quinoline-2-(carboxaldehyde) reagents for detection of primary amines
US5582702A (en) 1995-04-26 1996-12-10 Ethrog Biotechnology Ltd. Apparatus and method for electrophoresis
WO1998030684A1 (fr) 1997-01-08 1998-07-16 Life Technologies, Inc. Procedes de production de proteines
US7263719B2 (en) 2000-05-15 2007-08-28 Hewlett-Packard Development Company, L.P. System and method for implementing network security policies on a common network infrastructure
US20040014082A1 (en) 2000-08-11 2004-01-22 Invitrogen Corporation Highly homogeneous molecular markers for electrophoresis
US6562213B1 (en) 2000-08-30 2003-05-13 Ethrog Biotechnology Ltd. Electrophoresis apparatus for simultaneous loading of multiple samples
EP1668146B1 (fr) 2003-09-25 2014-11-12 Life Technologies Corporation Populations homogenes de molecules
EP1898938A4 (fr) 2005-06-27 2010-01-27 Life Technologies Corp Marqueurs de proteines sous forme liquide pour electrophorese native sur gel

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090178926A1 (en) * 2006-07-21 2009-07-16 Invitrogen Corporation Sharply Resolving Labeled Protein Molecular Weight Standards
WO2011025781A1 (fr) * 2009-08-24 2011-03-03 Life Technologies Corporation Electrophorèse sur gel, imagerie et procédés, dispositifs, systèmes et matériaux d'analyse
WO2011031497A2 (fr) * 2009-08-25 2011-03-17 Life Technologies Corporation Standards de protéine fluorescente quantitative

Also Published As

Publication number Publication date
WO2012149180A2 (fr) 2012-11-01

Similar Documents

Publication Publication Date Title
WO2011031497A3 (fr) Standards de protéine fluorescente quantitative
EA201590488A1 (ru) Способы модификации клеток-хозяев
EA201690529A1 (ru) Способы модификации клетки-хозяина
EA201491494A1 (ru) Нацеливание на гликаны хондроитинсульфаты
MX376235B (es) Antígenos asociados a próstata y regímenes de inmunoterapia basados en vacuna.
EP4368728A3 (fr) Quantification simultanée de l'expression génique dans une région définie par l'utilisateur d'un tissu en coupe transversale
CO6280541A2 (es) Anticuerpos monoclonales o fragmentos del mismo que se unen al recptor humano ox40
BR112013023006A2 (pt) formulações de suspensões não aquosas de anticorpos de alta concentração e viscosidade reduzida
EA201790968A1 (ru) Опосредуемая пептидом доставка направляемой рнк эндонуклеазы в клетки
HK1216894A1 (zh) 多價結合蛋白組合物
MY162737A (en) 4-1bb binding molecules
EA201490815A1 (ru) Составы этанерцепта, стабилизированные с помощью аминокислот
AU2013361107A8 (en) Human anti-tau antibodies
EP2269055A4 (fr) Préparation de mélanges liquides
WO2007067992A3 (fr) Anticorps monoclonaux humains se liant au fucosyl-gm1, et procedes d'utilisation de l'anti-fucosyl-gm1
AR089178A1 (es) Anticuerpos anti-il-36r
EA201101516A1 (ru) Антитела, специфические для кадгерина-17
MX2009005189A (es) Anticuerpos humanos monoclonales para btla y metodos de uso.
WO2011082415A3 (fr) Procédés, compositions et kits de récupération des acides nucléiques ou des protéines dans des échantillons de tissus fixés
EP2651411A4 (fr) Procédés et compositions permettant un marquage amélioré par le 18-f de protéines, de peptides et d'autres molécules
WO2016107818A8 (fr) Compositions et procédés de glycosylation de protéines
MX366622B (es) Composicion farmaceutica estable de la proteina de fusion tnfr:fc.
WO2007085923A8 (fr) Nouvelles protéines fluorescentes et procédés d'utilisation de celles-ci
WO2012149180A3 (fr) Colorant de suivi fluorescent
WO2008109533A3 (fr) Anticorps se liant à des protéines multiples de la famille irta et leurs utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12725173

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12725173

Country of ref document: EP

Kind code of ref document: A2